Nonimmunologic complications and gene polymorphisms of immunoregulatory cytokines in long-term renal transplants

Kidney International

Volumn 66, Issue 1, 2004, Pages 428-432

  Babel, Nina ^a   Cherepnev, Georgiy ^b   Kowalenko, Alexander ^b   Horstrup, Jan ^b   Volk, Hans Dieter ^b   Reinke, Petra ^b  

^a HUMBOLDT UNIVERSITY   (Germany)

^b NONE

Author keywords

Cytokine gene polymorphism; Nonimmunologic; Transplantation

Indexed keywords

CYTOKINE; STEROID; URIC ACID;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CODON; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSLIPOPROTEINEMIA; FEMALE; GAMMA INTERFERON GENE; GENE; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HYPERTENSION; HYPERURICEMIA; IMMUNOREGULATION; INTERLEUKIN 10 GENE; INTERLEUKIN 6 GENE; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSFORMING GROWTH FACTOR BETA1 GENE; TUMOR NECROSIS FACTOR ALPHA GENE;

EID: 3042725227     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00749.x     Document Type: Article

References (30)

1. BIDWELL J, KEEN L, GALLAGHER G, et al: Cytokine gene polymorphism in human disease: On-line databases, supplement 1. Genes Immun 2:61-70, 2001
2. CARTWRIGHT NH, KEEN L, DEMAINE AG, et al: A study of cytokine gene polymorphisms and protein secretion in renal transplantation. Transpl Immunol 8:237-244, 2001
3. FIRST MR: Strategies to minimize immunological and nonimmunological risk factors in the renal transplant population. Transplantation 72(6 Suppl):S20-24, 2001
4. BAUM CL: Weight gain and cardiovascular risk after organ transplantation. JPEN J Parenter Enteral Nutr 25:114-119, 2001
5. OGAWA A, JOHNSON JH, OHNEDA M, et al: Roles of insulin resistance and beta-cell dysfunction in dexamethasone-induced diabetes. J Clin Invest 90:497-504, 1992
6. GILLISON SL, BARTLETT ST, CURRY DL: Inhibition by cyclosporine of insulin secretion: A beta cell specific alteration of islet tissue function. Transplantation 52:890-895, 1991
7. SHIBA T, HIGASHI N, NISHIMURA Y: Hyperglycaemia due to insulin resistance caused by interferon-gamma. Diabet Med 15:435-436, 1998
8. VALYASEVI RW, JYONOUCHI SC, DUTTON CM, et al: Effect of tumor necrosis factor-alpha, interferon-gamma, and transforming growth factor-beta on adipogenesis and expression of thyrotropin receptor in human orbital preadipocyte fibroblasts. J Clin Endocrinol Metab 86:903-908, 2001
9. VAN HEUVEN-NOLSEN D, DE KIMPE SJ, MUIS T, et al: Opposite role of interferon-gamma and interleukin-4 on the regulation of blood pressure in mice. Biochem Biophys Res Commun 254:816-820, 1999
10. HOTAMISLIGIL GS, ARNER P, CARO JF, et al: Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest 95:2409-2415, 1995
11. LIU LS, SPELLEKEN M, ROHRIG K, et al: Tumor necrosis factor-α inhibits insulin signaling in human adipocytes: Implication of the p80 tumor necrosis factor receptor. Diabetes 47:515-522, 1998
12. WAITE KJ, FLOYD ZE, ARBOUR-REILY P, STEPHENS JM: Interferon-gamma-induced regulation of peroxisome proliferator-activated receptor gamma and STATs in adipocytes. J Biol Chem 276:7062-7068, 2001
13. BARROSO M, GURNELL VE, CROWLEY F, et al: Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 402:880-885, 1999
14. GAGNON AM, CHABOT J, PARDASANI D, SORISKY A: Extracellular matrix induced by TGFbeta impairs insulin signal transduction in 3T3-L1 preadipose cells. J Cell Physiol 175:370-378, 1998
15. STEFONI S, CIANCIOLO G, DONATI G, et al: Low TGF-beta1 serum levels are a risk factor for atherosclerosis disease in ESRD patients. Kidney Int 61:324-335, 2002
16. LI B, KHANNA A, SHARMA V, et al: TGF-beta1 DNA polymorphisms, protein levels, and blood pressure. Hypertension 33:271-275, 1999
17. TEGOSHI H, HASEGAWA G, OBAYASHI H, et al: Polymorphisms of interferon-gamma gene CA-repeat and interleukin-10 promoter region (-592A/C) in Japanese type I diabetes. Hum Immunol 63:121-128, 2002
18. PRAVICA V, PERREY C, STEVENS A, et al: A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: Absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Hum Immunol 61:863-866, 2000
19. LIO D, SCOLA L, CRIVELLO A, et al: Allele frequencies of +874T → A single nucleotide polymorphism at the first intron of interferon-gamma gene in a group of Italian centenarians. Exp Gerontol 37:315-319, 2002
20. AMRANI A, VERDAGUER J, THIESSEN S, et al: IL-1alpha, IL-1beta, and IFN-gamma mark beta cells for Fas-dependent destruction by diabetogenic CD4(+) T lymphocytes. J Clin Invest 105:459-468, 2000
21. CHONG MM, THOMAS HE, KAY TW: Gamma-interferon signaling in pancreatic beta-cells is persistent but can be terminated by overexpression of suppressor of cytokine signaling-1. Diabetes 50:2744-2751, 2001
22. ZHU XP, SATOH J, MUTO G, et al: Improvement of glucose tolerance with immunomodulators on type 2 diabetic animals. Biotherapy 9:189-197, 1996
23. CAMBIEN F, RICARD S, TROESCH A, et al: Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Temoin de l'Infarctus du Myocarde (ECTIM) Study. Hypertension 28:881-887, 1996
24. AWAD MR, EL-CAMEL A, HASLETON P, et al: Genotypic variation in the transforming growth factor-β1 gene. Transplantation 66:1014-1020, 1998
25. ALESSI MC, BASTELICA D, MORANGE P, et al: Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity. Diabetes 49:1374-1380, 2000
26. GOTTSCHLING-ZELLER H, BIRGEL M, SCRIBA D, et al: Depot-specific release of leptin from subcutaneous and omental adipocytes in suspension culture: Effect of tumor necrosis factor-alpha and transforming growth factor-beta1. Eur J Endocrinol 141:436-442, 1999
27. Targeting links between obesity and diabetes. 2001. http://www. leaddiscovery.co.uk/dossiers/0454/index.html.
28. SANDERSON N, FACTOR V, NAGY P, et al: Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci USA 92:2572-2576, 1995
29. GIBSON AW, EDBERG JC, WU J, et al: Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J Immunol 166:3915-3922, 2001
30. TURNER DM, WILLIAMS DM, SANKARAN D, et al: An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 24:1-8, 1997